Back to Search
JEFFREY MICHAEL KAMRADT MD
MD
Hematology & Oncology Physician
NPI: 1912949165IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
037516(CT)
Education
INDIANA UNIVERSITY SCHOOL OF MEDICINE
Class of 1993
Research & Publications (20)
[Extending the limits of lymphadenectomy during radical cystectomy: pitfalls in the interpretation of contemporary study results].
PMID 19169660·Urologe A·2009
6-review
Important aspects of organ-preserving surgery for renal tumors: indications, new standards, and oncological outcomes.
PMID 19568369·Dtsch Arztebl Int·2009
6-review
Surgery for metastatic urothelial carcinoma with curative intent: the German experience (AUO AB 30/05).
PMID 19058907·Eur Urol·2009
4-observational
DNA methylation biomarkers of prostate cancer: confirmation of candidates and evidence urine is the most sensitive body fluid for non-invasive detection.
PMID 19459176·Prostate·2009
8-other
[Complete resection of urothelial cancer metastases with curative intent].
PMID 19142626·Urologe A·2009
3-trial
[Development of a three-dimensional primary prostate cancer cell culture model].
PMID 18682911·Urologe A·2008
8-other
Antimicrobial peptides of the Cecropin-family show potent antitumor activity against bladder cancer cells.
PMID 18315881·BMC Urol·2008
8-other
Combining 153Sm-lexidronam and docetaxel for the treatment of patients with hormone-refractory prostate cancer: first experience.
PMID 18999933·Cancer Biother Radiopharm·2008
8-other
Outcome of prostate cancer patients with initial PSA> or =20 ng/ml undergoing radical prostatectomy.
PMID 17418938·Eur Urol·2007
8-other
An improved in vitro model to characterize invasive growing cancer cells simultaneously by function and genetic aberrations.
PMID 17126525·Toxicol In Vitro·2007
8-other
Improving the prognosis of patients after radical cystectomy. Part I: the role of lymph node dissection.
PMID 17979920·BJU Int·2007
6-review
Improving the prognosis of patients after radical cystectomy. Part II: the role of perioperative chemotherapy.
PMID 17979921·BJU Int·2007
6-review
Detection of novel amplicons in prostate cancer by comprehensive genomic profiling of prostate cancer cell lines using oligonucleotide-based arrayCGH.
PMID 17712417·PLoS One·2007
8-other
Transitional cell carcinoma of the ureter: prognostic factors influencing progression and survival.
PMID 17125909·Eur Urol·2007
8-other
Genomic and expression analysis of the 3q25-q26 amplification unit reveals TLOC1/SEC62 as a probable target gene in prostate cancer.
PMID 16547154·Mol Cancer Res·2006
8-other
Relationship of NKX3.1 and MYC gene copy number ratio and DNA hypomethylation to prostate carcinoma stage.
PMID 16310933·Eur Urol·2006
8-other
Evidence for gains at 15q and 20q in brain metastases of prostate cancer.
PMID 15474146·Cancer Genet Cytogenet·2004
5-case
Adrenal metastases in 1635 patients with renal cell carcinoma: outcome and indication for adrenalectomy.
PMID 15126776·J Urol·2004
8-other
Analysis of the vitamin D system in basal cell carcinomas (BCCs).
PMID 15077124·Lab Invest·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 85 RETREAT AVE
HARTFORD, CT 06106 - Phone
- (860) 249-6291
Quick Facts
- NPI
- 1912949165
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 33
- Publications
- 20
Are you this provider?
Claim Your Profile